Evofem Biosciences (EVFM) Competitors $0.01 0.00 (-10.53%) As of 09/16/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EVFM vs. CMND, INM, ONCO, JAGX, ENTO, TRIB, SLXN, PWUP, EVAX, and REVBShould you be buying Evofem Biosciences stock or one of its competitors? The main competitors of Evofem Biosciences include Clearmind Medicine (CMND), InMed Pharmaceuticals (INM), Onconetix (ONCO), Jaguar Animal Health (JAGX), Entero Therapeutics (ENTO), Trinity Biotech (TRIB), Silexion Therapeutics (SLXN), PowerUp Acquisition (PWUP), Evaxion A/S (EVAX), and Revelation Biosciences (REVB). These companies are all part of the "pharmaceutical products" industry. Evofem Biosciences vs. Its Competitors Clearmind Medicine InMed Pharmaceuticals Onconetix Jaguar Animal Health Entero Therapeutics Trinity Biotech Silexion Therapeutics PowerUp Acquisition Evaxion A/S Revelation Biosciences Evofem Biosciences (NASDAQ:EVFM) and Clearmind Medicine (NASDAQ:CMND) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership. Does the media favor EVFM or CMND? In the previous week, Clearmind Medicine had 1 more articles in the media than Evofem Biosciences. MarketBeat recorded 3 mentions for Clearmind Medicine and 2 mentions for Evofem Biosciences. Clearmind Medicine's average media sentiment score of 1.42 beat Evofem Biosciences' score of -0.01 indicating that Clearmind Medicine is being referred to more favorably in the news media. Company Overall Sentiment Evofem Biosciences Neutral Clearmind Medicine Positive Do insiders and institutionals believe in EVFM or CMND? 0.2% of Evofem Biosciences shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 0.0% of Evofem Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, EVFM or CMND? Evofem Biosciences has a beta of -1.11, meaning that its share price is 211% less volatile than the S&P 500. Comparatively, Clearmind Medicine has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Is EVFM or CMND more profitable? Clearmind Medicine has a net margin of 0.00% compared to Evofem Biosciences' net margin of -46.42%. Evofem Biosciences' return on equity of -91.97% beat Clearmind Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Evofem Biosciences-46.42% -91.97% -61.93% Clearmind Medicine N/A -173.87%-70.55% Which has higher valuation & earnings, EVFM or CMND? Evofem Biosciences has higher revenue and earnings than Clearmind Medicine. Clearmind Medicine is trading at a lower price-to-earnings ratio than Evofem Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvofem Biosciences$11.39M0.14$52.98M-$0.07-0.19Clearmind MedicineN/AN/A-$5.26M-$0.76-1.33 SummaryEvofem Biosciences beats Clearmind Medicine on 7 of the 12 factors compared between the two stocks. Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EVFM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVFM vs. The Competition Export to ExcelMetricEvofem BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.61M$850.45M$5.73B$10.31BDividend YieldN/A4.84%5.90%4.63%P/E Ratio-0.021.1775.8626.51Price / Sales0.1426.62528.72123.58Price / CashN/A19.5637.1760.46Price / Book-0.016.5812.796.29Net Income$52.98M-$4.18M$3.28B$270.51M7 Day PerformanceN/A2.22%0.81%1.95%1 Month PerformanceN/A7.81%4.60%6.33%1 Year PerformanceN/A20.14%70.39%25.62% Evofem Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVFMEvofem Biosciences0.8374 of 5 stars$0.01-10.5%N/A+41.7%$1.61M$11.39M-0.02120Gap UpHigh Trading VolumeCMNDClearmind Medicine1.4101 of 5 stars$1.03+2.2%N/A-24.1%$4.41MN/A-0.94N/AEarnings ReportShort Interest ↓Gap UpINMInMed Pharmaceuticals1.2479 of 5 stars$2.16+0.4%N/A-53.9%$4.32M$4.60M-0.1810News CoveragePositive NewsShort Interest ↓Gap DownONCOOnconetix0.8929 of 5 stars$2.71+1.1%N/A-99.2%$4.20M$2.52M0.0012JAGXJaguar Animal Health1.6376 of 5 stars$1.94-2.1%$60.00+2,994.4%-92.8%$4.20M$11.69M0.0050Short Interest ↑ENTOEntero TherapeuticsN/A$2.53-3.8%N/A+269.7%$4.06MN/A0.009Positive NewsTRIBTrinity Biotech1.5211 of 5 stars$1.13+0.4%N/A-85.2%$4.06M$61.56M-0.08480Gap DownSLXNSilexion Therapeutics2.7458 of 5 stars$5.54-22.0%$75.00+1,255.0%-97.2%$4.05MN/A0.00N/APWUPPowerUp AcquisitionN/A$0.510.0%N/A-96.4%$3.97MN/A0.00N/AGap UpHigh Trading VolumeEVAXEvaxion A/S2.5421 of 5 stars$2.83-4.2%$10.00+254.0%-81.9%$3.96M$3.34M-2.1460News CoverageGap UpREVBRevelation Biosciences0.8523 of 5 stars$2.31-18.3%N/A-96.3%$3.90MN/A-0.0310Gap DownHigh Trading Volume Related Companies and Tools Related Companies Clearmind Medicine Alternatives InMed Pharmaceuticals Alternatives Onconetix Alternatives Jaguar Animal Health Alternatives Entero Therapeutics Alternatives Trinity Biotech Alternatives Silexion Therapeutics Alternatives PowerUp Acquisition Alternatives Evaxion A/S Alternatives Revelation Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVFM) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evofem Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVFM Stock Alerts